Evaluation of NK1 Antagonist in Post-Traumatic Stress
ID Number 04-0900Principal Investigator(s)
Dan V. Iosifescu
Department(s) or Division(s)
The purpose of this study is to test the safety and effectiveness of an experimental drug for PTSD, GSK561679, compared to a placebo, which is a pill with no active substance. Patients may qualify for participation in this study if they have a diagnosis of PTSD, and have current symptoms of the disorder.
Recruiting Patients: Yes